Treatment other concepts

dd admin
32336674 ä. COVID-19 Emergency Responders in FDA?s Center for Drug Evaluation and Research
32243778 2020. Ensuring global access to COVID-19 vaccines
32247324 2020. Global coalition to accelerate COVID-19 clinical research in resource-limited settings

C7194243 ä. Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion
32383008 ä. The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic

Neuromodulation
32458400 2020. Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19.
32342609 2020. The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience.

Surfactant
32401611 2020. The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses.
32579022 2020. Lung Mechanics in COVID-19 Resemble RDS not ARDS: Could Surfactant be a Treatment?
32574339 2020. Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia.
32582137 2020. Biosurfactants: A Covid-19 Perspective.

Immunonutrition
32531935 2020. Chronic Inflammation in the Context of Everyday Life: Dietary Changes as Mitigating Factors.
32229705 2020. Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections
32276453 2020. Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats
32384188 2020. Parenteral Fish-Oil Emulsions in Critically Ill COVID-19 Emulsions.

32376108 2020. Archetype analysis of older adult immunization decision-making and implementation in 34 countries.
32578073 2020. Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition.

Chronotherapy
32442317 2020. The case for Chronotherapy in COVID-19 induced Acute Respiratory Distress Syndrome (ARDS).

Hyperbaric oxygen HBO2

32574447 2020. HBO2 for COVID-19: Clinical trials at clinicaltrials.gov.
32574446 2020. UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients.
32574433 2020. Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
32574432 2020. Hyperbaric oxygen as a treatment for COVID-19 infection?

32541129 2020. Intermittent high dosage oxygen treats COVID-19 infection: the Chinese studies.
32541128 2020. Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure.

Hot air
32550078 2020. Heated Air Delivery by Micro-Sauna: An Experimental Treatment Prototype Concept for Coronavirus Disease 2019. ad F
32220289 2020. Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility.
32482418 2020. Research during SARS-CoV-2 pandemic: To "Preprint" or not to "Preprint", that is the question.

ad A
32413736 2020. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.
32534188 2020. Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A global pandemic and treatments strategies.
32315803 2020. Preliminary therapeutic drug monitoring data of beta-lactams in critically ill patients with SARS-CoV-2 infection.
32532623 2020. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
32390307 2020. Practical tips for using masks in the COVID-19 pandemic.
32496248 2020. Effectiveness of preventive measures against COVID-19: A systematic review of In Silico modeling studies in indian context.
32496246 2020. Impact of nonpharmacological interventions on COVID-19 transmission dynamics in India.
32505040 2020. The end of 'cordon sanitaire' in Wuhan: the role of non-pharmaceutical interventions against COVID-19.
32403134 2020. Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic.
32512579 2020. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.
32116200 2020. COVID-19: Perspectives on the Potential Novel Global Threat.
32463459 2020. Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States.
32472939 2020. Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland.
32491981 2020. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures.
32487283 2020. Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020.
32407551 2020. Interrogation of the safety and efficacy of home-use light-based devices.
32429705 2020. COVID-19 and Nutrition: The Need for Initiatives to Promote Healthy Eating and Prevent Obesity in Childhood.
32325124 ä. Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals
32312129 2020. The role of additive manufacturing and antimicrobial polymers in the COVID-19 pandemic
32356251 ä. Medical Toxicology and COVID-19: Our Role in a Pandemic
32272857 2020. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks
32129977 2020. Cell-Membrane-Mimicking Nanodecoys against Infectious Diseases
29115746 2018. Progress Toward the Clinical Translation of Bioinspired Peptide and Protein Assemblies
29717819 2018. Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens
32426002 2020. Opciones Terapeuticas En El Manejo De Covid-19 Grave: Una Perspectiva De Reumatologia.
32558354 2020. Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load.
32562159 2020. The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
32565309 2020. Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019.
32593196 2020. The Another Side of COVID-19 in Alzheimer's Disease Patients: Drug-Drug Interactions.
32520770 2020. Overview of Coronavirus Disease 2019 (COVID-19): Treatment Updates and Advances.
32284797 2020. We have to write and share valid and reliable information on COVID-19.
32487093 2020. The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.
32405428 2020. Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections, 8-11 March 2020, Boston, USA.
32425304 2020. Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?
32393381 2020. Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19 infected healthcare workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey.
32439309 2020. Revision narrativa sobre la respuesta inmunitaria frente a coronavirus: descripcion general, aplicabilidad para SARS-COV-2 e implicaciones terapeuticas.
32504103 2020. Ten things we learned about COVID-19.
32494929 2020. COVID-19: 10 things I wished I'd known some months ago.
32546867 2020. Why children avoid the worst coronavirus complications might lie in their arteries.

ad P
32388537 2020. Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro).
32532959 2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.
32423553 2020. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.
32531235 2020. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
32430279 2020. Gut microbiota and Covid-19- possible link and implications.
32416259 2020. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.
32558150 2020. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.
32585135 2020. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
32546195 2020. Micronutrient status of COVID-19 patients: a critical consideration.
32559343 2020. Rationale for targeting Complement in COVID-19.
32543705 2020. Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition.
32592394 2020. A role for selenium-dependent GPX1 in SARS-CoV-2 virulence.
32590326 2020. Pulmonary surfactant itself must be a strong defender against SARS-CoV-2.
32562814 2020. Statins and other drugs: Facing COVID-19 as a vascular disease.
32424591 2020. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
32598884 2020. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
32481719 2020. The Role of MicroRNA in the Airway Surface Liquid Homeostasis.
32534506 2020. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
32600316 2020. The cholinergic anti-inflammatory pathway alleviates acute lung injury.
32537478 2020. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.
32595361 2020. Gut-lung axis and dysbiosis in COVID-19.
32591496 2020. Door to the cell for COVID-19 opened, leading way to therapies.
32602262 2020. Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.
32555145 2020. Targeting the entry step of SARS-CoV-2: a promising therapeutic approach.
32594085 2020. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.
32582574 2020. ACE2, Much More Than Just a Receptor for SARS-COV-2.
32545271 2020. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract.

32593832 2020. Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis.

32573788 2020. Elucidation of Cellular Targets and Exploitation of the Receptor Binding Domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis.
32551652 2020. Critical Differences Between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV.
32551648 2020. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach.
32571797 2020. Identification of common deletions in the spike protein of SARS-CoV-2.
32606248 2020. Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface.
32602627 2020. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.

ad R
32401215 2020. Telehealth Home Support During COVID-19 Confinement for Community-Dwelling Older Adults With Mild Cognitive Impairment or Mild Dementia: Survey Study.
32468385 2020. Musings on the current state of COVID-19 modeling and reporting.
32516380 2020. Covid-19's Impact on Podiatry in Chicago's Largest Public Hospital.
32406749 2020. Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care.
32498081 2020. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
32510719 2020. Intramatricial methotrexate for treatment of resistant acrodermatitis continua of Hallopeau: an alterative in Covid-19.
32500633 2020. "Thinking outside the box in COVID-19 era"-Application of Modified Aerosol Box in Dermatology.
32587103 2020. Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?
32601278 2020. Numerical evaluation of spray position for improved nasal drug delivery.
32412787 2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.
32548601 2020. Ventilation in the Dental Clinic: An Effective Measure to Control Droplets and Aerosols during the Coronavirus Pandemic and Beyond.
32548600 2020. Preventive and Control Measures for the Coronavirus Pandemic in Clinical Dentistry.
32540791 2020. Upper and Lower Airways Functional Examination in Asthma and Respiratory Allergic Deseases. Considerations in the SARS-CoV-2 Post-Pandemic Situation.

ad D
32358890 2020. Cutaneous side-effects of the potential COVID-19 drugs.
32561682 2020. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype.
32426558 2020. Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against "SARS-CoV-2 nephropathy".
32534339 2020. A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?
32423974 2020. COVID-19 and Rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics?
32475104 2020. Coronavirus Disease 2019 Presenting as Conjunctivitis.
32591314 2020. Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient.
32585161 2020. Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis.

32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32437740 2020. The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China.

ad misc2
32464736 2020. A simulation training course for family medicine residents in China managing COVID-19.

ad pol
32552021 2020. From "Infodemics" to Health Promotion: A Novel Framework for the Role of Social Media in Public Health.

ad E
32577840 2020. Introduction: microbes, networks, knowledge-disease ecology and emerging infectious diseases in time of COVID-19.
32246939 2020. SARS-CoV-2 in wastewater: potential health risk, but also data source.
32526937 2020. Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak.

32604468 2020. CoViD-19 epidemic follows the "kinetics" of enzymes with cooperative substrate binding.

32534626 2020. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
32583766 2020. Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020.

ad X
32542429 2020. Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression.
32564017 2020. The Role of Genetic Sex and Mitochondria in Response to COVID-19 Infection.

32557383 2020. Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients.

32561682 2020. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype.
32594342 2020. Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19.
32574283 2020. Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics.